Luminary Therapeutics
Minneapolis, MN · Biotechnology · 10 employees
Luminary is a clinical stage CAR-T therapy company with a novel allogeneic manufacturing platform where our CAR and or TCR development utilizes gamma delta cells. What makes our allogeneic therapeutics unique are that our final drug product includes the combinatory power of both the Vẟ1 and Vẟ2 gamma delta cells giving our therapies the power of both innate and adaptive cancer clearing power. We h
Funding history
- Funding Round — $1.4M — Nov 2025
- Funding Round — $5.2M — Jan 2025
- Funding Round — $5.2M — Jan 2025
- Series seed — $2.4M — Aug 2023
- Series seed — $2.2M — Jan 2023
Recent signals
- Nov 05, 2025: Raised $1.4M
- Jan 08, 2025: Raised $5.2M
- Jan 08, 2025: Raised $5.2M
- Aug 03, 2023: Raised $2.4M in Series seed
- Jan 11, 2023: Raised $2.2M in Series seed
- Nov 04, 2021: Raised $375K
- Feb 09, 2021: Raised $825K
- Nov 14, 2019: Raised $5.2M
See plans & pricing → Track Luminary Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.